Robert Aurigema
Our team

Robert Aurigema

Partner, Chief Operating Officer and Chief Financial Officer

Robert is a partner and Chief Financial Officer of RTW, leading the Firm Services division responsible for oversight of all of the firm’s financial and operating activities. He has built and developed an operations and finance team to enable RTW’s continued growth and evolution into a global life sciences investment firm.

Robert has extensive management and leadership experience having spent over 25 years building, servicing and managing investment companies across almost all sectors, strategies and major geographies. Prior to joining RTW, Robert spent six years as Chief Operating Officer and Chief Financial Officer at Balyasny Asset Management, a global multi-strategy, multi-manager hedge fund. Prior to BAM, Robert was the Chief Financial Officer and Chief Operating Officer for Plural Investments, a multi-manager hedge fund that he helped launch. Robert started his buy-side career at SAC Capital, where he built and managed all middle and back office functions and teams globally as Director of Operations. Robert has also served as COO, CFO, and CCO of SECOR Asset Management, and Global Head of Operations at Avenue Capital Group. He began his sell side career as a vice president at Goldman Sachs in their Prime Brokerage Division. Robert started his career at Deloitte & Touche in their Financial Instruments and Strategies Division.

RTW is steadfast in its commitment to fostering medical research and innovation while delivering unprecedented value to all stakeholders and society as a whole. It is an honor to be part of this incomparable team at such a pivotal time in the history of scientific advancement.

Robert received a BS in Accounting from Villanova University and is a licensed CPA. He holds certifications from University of Oxford in Executive Leadership and from the London School of Economics in Data Analysis.